0882

Category

• Goods >> Health & Beauty >> Personal Hygiene >> Feminine Hygiene Products
• Goods >> Health & Beauty >> Personal Hygiene >> Other Products For Personal Pharmacy
• Goods >> Health & Beauty >> Personal Hygiene >> Disposable Toilet Seat Covers

Description

The EarlyTect Colon Cancer Test is a highly reliable and effective screening tool for the early detection of colorectal cancer. This product has been extensively tested and approved by the Korea Ministry of Food and Drug Safety, with clinical trials conducted at renowned medical centers. The trials involved 585 men and women, aged 30 to 80, who were eligible subjects for the study. Through the use of fecal DNA analysis, these trials demonstrated that the test can diagnose colorectal cancer with an impressive accuracy of 90% sensitivity and specificity.

The EarlyTect Colon Cancer Test is a qualitative real-time PCR test that specifically measures methylated Syndecan-2, a biomarker associated with precancerous lesions of colorectal cancer, in stool DNA. By analyzing the levels of this biomarker, medical professionals can identify the presence of colorectal cancer at an early stage. It is important to note that this test is not designed to provide a conclusive confirmation of colorectal cancer. If a subject tests positive for the biomarker, further investigations may be necessary to determine the presence of colorectal cancer or precancerous lesions.

The product meets the following standards:
- Cancer Type: Specifically designed for colorectal cancer screening
- Subject: Intended for asymptomatic individuals who require colorectal cancer screening
- Biomarker: Measures the presence of methylated Syndecan-2 in stool DNA

The price and transaction conditions for the EarlyTect Colon Cancer Test are negotiable. Please request a quote to proceed with the transaction.